T1	Participants 63 100	postmenopausal women with osteopenia:
T2	Participants 529 655	81 postmenopausal osteopenic women to 1-yr nightly treatment with melatonin 1 mg (N = 20), 3 mg (N = 20), or placebo (N = 41).
T3	Participants 903 958	Mean age of the study subjects was 63 (range 56-73) yr.
